⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2059573 | 0.80 | CA2 (0.30) | — | |
| SCHEMBL2059582 | 0.76 | — | — | |
| SCHEMBL10570362 | 0.76 | — | — | |
| SCHEMBL8149462 | 0.74 | — | — | |
| SCHEMBL3159776 | 0.71 | — | — | |
| SCHEMBL168925 | 0.71 | — | — | |
| SCHEMBL7041191 | 0.67 | — | — | |
| SCHEMBL9302567 | 0.67 | — | — | |
| SCHEMBL3266926 | 0.66 | — | — | |
| SCHEMBL2059584 | 0.66 | ALDH1A1 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6727279-B2 | CENTRAL NERVOUS SYSTEM DISORDERS | BAYER AKTIENGESELLSCHAFT (DE) | 2004-04-27 | — | — | US | claimed |
| US-20030073727-A1 | Novel arylsulphonamides and analogues | MITTENDORF JOACHIM (DE) | 2003-04-17 | — | — | US | claimed |
| EP-0747350-B1 | PROCESS FOR PRODUCING BIS(4-ALKYLTHIOPHENYL) DISULFIDE | TORAY INDUSTRIES (JP) | 2003-03-19 | — | — | EP | claimed |
| EP-0966436-B1 | ARYL SULFONAMIDES AND ANALOGUES THEREOF AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES | BAYER AG (DE) | 2002-12-11 | — | — | EP | claimed |
| US-6469054-B1 | PROPHYLAXIS AND TREATMENT OF NEURODEGENERATIVE DISORDERS, IN PARTICULAR FOR THE TREATMENT OF CEREBRAL APOPLEXY, CRANIOCEREBRAL TRAUMA, PAIN AND SPASTICITY | BAYER AKTIENGESELLSHAFT (DE) | 2002-10-22 | — | — | US | claimed |
| US-20020072529-A1 | Arylsulfonamides and analogues | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2002-06-13 | — | — | US | claimed |
| EP-0747350-A1 | PROCESS FOR PRODUCING BIS(4-ALKYLTHIOPHENYL) DISULFIDE | TORAY INDUSTRIES, INC. (JP) | 1996-12-11 | — | — | EP | claimed |
| US-6727279-B2 | CENTRAL NERVOUS SYSTEM DISORDERS | BAYER AKTIENGESELLSCHAFT (DE) | 2004-04-27 | — | — | US | disclosed |
| US-6573278-B2 | For therapy and prophylaxis of cerebral apoplexy and craniocerebral trauma | BAYER AKTIENGESELLSCHAFT (DE) | 2003-06-03 | — | — | US | disclosed |
| US-20030073727-A1 | Novel arylsulphonamides and analogues | MITTENDORF JOACHIM (DE) | 2003-04-17 | — | — | US | disclosed |
| US-6545050-B1 | Prophylaxis and treatment of neurodegenerative disorders, in particular for the treatment of cerebral apoplexy, craniocerebral trauma, pain and spasticity. | BAYER AKTIENGESELLSCHAFT (DE) | 2003-04-08 | — | — | US | disclosed |
| EP-0747350-B1 | PROCESS FOR PRODUCING BIS(4-ALKYLTHIOPHENYL) DISULFIDE | TORAY INDUSTRIES (JP) | 2003-03-19 | — | — | EP | disclosed |
| US-6469054-B1 | PROPHYLAXIS AND TREATMENT OF NEURODEGENERATIVE DISORDERS, IN PARTICULAR FOR THE TREATMENT OF CEREBRAL APOPLEXY, CRANIOCEREBRAL TRAUMA, PAIN AND SPASTICITY | BAYER AKTIENGESELLSHAFT (DE) | 2002-10-22 | — | — | US | disclosed |
| US-20020072529-A1 | Arylsulfonamides and analogues | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2002-06-13 | — | — | US | disclosed |
| US-6262112-B1 | 1-(4,4,4-TRIFLUOROBUTYLSULPHONYLOXY)-3-(2-(HYDROXYMETHYL)INDAN -4-YLOXY)-BENZENE | BAYER AKTIENGESELLSCHAFT (DE) | 2001-07-17 | — | — | US | disclosed |
| US-5986143-A | Method of producing bis(4-alkylthiophenyl) disulfides | TORAY INDUSTRIES, INC. (JP) | 1999-11-16 | — | — | US | disclosed |
| EP-0747350-A1 | PROCESS FOR PRODUCING BIS(4-ALKYLTHIOPHENYL) DISULFIDE | TORAY INDUSTRIES, INC. (JP) | 1996-12-11 | — | — | EP | disclosed |